Retinal changes in Alzheimer's disease—integrated prospects of imaging, functional and molecular advances
Alzheimer's Disease (AD) is a devastating neurodegenerative disorder of the brain, clinically
characterised by cognitive deficits that gradually worsen over time. There is, at present, no …
characterised by cognitive deficits that gradually worsen over time. There is, at present, no …
[HTML][HTML] Retinal dysfunction in Alzheimer's disease and implications for biomarkers
C Liao, J Xu, Y Chen, NY Ip - Biomolecules, 2021 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that manifests as
cognitive deficits and memory decline, especially in old age. Several biomarkers have been …
cognitive deficits and memory decline, especially in old age. Several biomarkers have been …
Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis
Objectives The prevalence of sensory impairment at an early stage of amyotrophic lateral
sclerosis (ALS) is still debated. The study aim was to investigate the anatomofunctional …
sclerosis (ALS) is still debated. The study aim was to investigate the anatomofunctional …
Protective effects of 7, 8-dihydroxyflavone on retinal ganglion and RGC-5 cells against excitotoxic and oxidative stress
VK Gupta, Y You, JC Li, A Klistorner… - Journal of Molecular …, 2013 - Springer
A preferential loss of retinal ganglion cells (RGCs) is observed in glaucoma and optic
neuritis. Loss of tropomyosin-related kinase receptor B (TrkB)-mediated signaling has been …
neuritis. Loss of tropomyosin-related kinase receptor B (TrkB)-mediated signaling has been …
Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss
Y You, VK Gupta, JC Li, A Klistorner… - Reviews in the …, 2013 - degruyter.com
Optic neuropathy refers to dysfunction and/or degeneration of axons of the optic nerve with
subsequent optic nerve atrophy. A common feature of different optic neuropathies is retinal …
subsequent optic nerve atrophy. A common feature of different optic neuropathies is retinal …
[HTML][HTML] Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner
M Abbasi, VK Gupta, N Chitranshi, V Gupta… - Theranostics, 2021 - ncbi.nlm.nih.gov
SH2 domain containing tyrosine phosphatase 2 (Shp2; PTPN11) regulates several
intracellular pathways downstream of multiple growth factor receptors. Our studies implicate …
intracellular pathways downstream of multiple growth factor receptors. Our studies implicate …
Retinal proteomics of experimental glaucoma model reveal intraocular pressure‐induced mediators of neurodegenerative changes
M Mirzaei, VK Gupta, N Chitranshi… - Journal of cellular …, 2020 - Wiley Online Library
Current evidence suggests that exposure to chronically induced intraocular pressure (IOP)
leads to neurodegenerative changes in the inner retina. This study aimed to determine …
leads to neurodegenerative changes in the inner retina. This study aimed to determine …
Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis
Y You, MH Barnett, C Yiannikas, J Parratt… - Neurology …, 2020 - AAN Enterprises
Objective To examine the effect of chronic demyelination in the optic nerve of patients with
MS on progressive loss of retinal ganglion cell (RGC) axons. Methods Progressive retinal …
MS on progressive loss of retinal ganglion cell (RGC) axons. Methods Progressive retinal …
The role of CREB, SRF, and MEF2 in activity-dependent neuronal plasticity in the visual cortex
NS Pulimood, W dos Santos Rodrigues… - Journal of …, 2017 - Soc Neuroscience
The transcription factors CREB (cAMP response element binding factor), SRF (serum
response factor), and MEF2 (myocyte enhancer factor 2) play critical roles in the …
response factor), and MEF2 (myocyte enhancer factor 2) play critical roles in the …
[HTML][HTML] Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin
Neuroserpin is a serine protease inhibitor that regulates the activity of plasmin and its
activators in the neuronal tissues. This study provides novel evidence of regulatory effect of …
activators in the neuronal tissues. This study provides novel evidence of regulatory effect of …